|
B3GNT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.418400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.063600E-02 |
| Normal-vs-Stage2 |
1.266420E-01 |
| Normal-vs-Stage3 |
2.151900E-02 |
| Normal-vs-Stage4 |
8.629600E-02 |
| Stage1-vs-Stage2 |
5.292800E-01 |
| Stage1-vs-Stage3 |
5.075200E-01 |
| Stage1-vs-Stage4 |
2.868800E-01 |
| Stage2-vs-Stage3 |
7.989600E-01 |
| Stage2-vs-Stage4 |
6.390600E-01 |
| Stage3-vs-Stage4 |
3.380800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.365900E-04 |
| Normal-vs-AfricanAmerican |
4.245700E-02 |
| Normal-vs-Asian |
7.674800E-01 |
| Caucasian-vs-AfricanAmerican |
7.631400E-01 |
| Caucasian-vs-Asian |
3.659000E-01 |
| AfricanAmerican-vs-Asian |
5.477400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.519100E-03 |
| Normal-vs-Female |
6.959300E-04 |
| Male-vs-Female |
8.195700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.189700E-02 |
| Normal-vs-Extreme_Weight |
3.957500E-02 |
| Normal-vs-Obese |
3.537100E-03 |
| Normal-vs-Extreme_Obese |
2.155400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.928400E-01 |
| Normal_Weight-vs-Obese |
5.462000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.734200E-01 |
| Extreme_Weight-vs-Obese |
3.046400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.120600E-01 |
| Obese-vs-Extreme_Obese |
9.774600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.321700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.764900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.672400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.839000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.817630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.521500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.948300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.051820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.567390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.554600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.301500E-03 |
| Normal-VS-Type2 PRCC |
2.559600E-01 |
| Normal-VS-KIRP CIMP |
1.617570E-02 |
| Normal-VS-Unclassified PRCC |
8.355900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.102400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.425700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.047000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.654000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.465370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.795700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.533230E-01 |
| Normal-vs-N1 |
1.240950E-03 |
| Normal-vs-N2 |
2.499400E-01 |
| N0-vs-N1 |
2.987800E-02 |
| N0-vs-N2 |
1.368750E-01 |
| N1-vs-N2 |
6.539400E-01 |
|
|
